Skip to content

Deferred Revenue at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.93B+2.2%
Agilent Technologies logo
Agilent TechnologiesA
$433M+0.9%
TEC
Bio-TechneTECH
$38.43M+19.1%
Danaher logo
DanaherDHR
Illumina logo
IlluminaILMN
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's deferred revenue?
Twist Bioscience Corporation (TWST) reported deferred revenue of $16.6M in Q1 2026.
How has Twist Bioscience Corporation's deferred revenue changed year-over-year?
Twist Bioscience Corporation's deferred revenue increased by 95.3% year-over-year, from $8.5M to $16.6M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.